An Illinois federal jury awarded an Oregon man $3.2 million, finding drug maker AbbVie Inc., was negligent in its promotion of the testosterone replacement therapy AndroGel. The verdict in the case of plaintiff Jesse Mitchell came after a more than two-week-long trial and resulted in an award of $200,000 in compensatory damages and $3 million in punitive damages. It was the second time a jury deliberated on whether AndroGel caused Mitchell’s heart attack. The first trial ended last summer with a jury finding AndroGel was not the cause of Mitchell’s heart attack and thus no compensatory damages were awarded. But the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.